Stacy Wang possesses extensive experience in healthcare and pharmaceutical market research and brand analytics. Currently serving as the Director of Commercial Insights for both Oncology and Inflammation at Amgen, Stacy leads a team supporting major products such as OTEZLA, Tezspire, Enbrel, and Amjevita. Prior experience includes the role of Brand Insight Director at AstraZeneca, where support was provided for the growth of BRILINTA® during critical launch periods, and as Director of Market Research & New Product Planning at Aclaris Therapeutics, establishing market strategies for FDA approval. Additional roles at Allergan and CVS/pharmacy included managing business insights and pharmacy operations. Educational qualifications include a PharmD from Creighton University and a B.S. in Biological Sciences from UC Irvine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices